Product Description: PRMT5-MTA-IN-3-d3 (compound P22) is the deuterium labeled PRMT5-MTA-IN-3 (HY-172733). PRMT5-MTA-IN-3-d3 is an orally active PRMT5-MTA inhibitor. PRMT5-MTA-IN-3-d3 has antiproliferative effects on HTC116-MTAP del and wild type colorectal cancer HCT-116 cell lines, with IC50 values of 6 nM and 961 nM, respectively. PRMT5-MTA-IN-3-d3 has anticancer effects, especially for MTAP-deficient tumors, such as non-small cell lung cancer (NSCLC), pancreatic cancer[1].
Applications: Cancer-programmed cell death
Formula: C19H14D3F3N6O3
References: [1]Bing Liu, et al. Inhibiteur de prmt5-mta. WO2024152973A1.
CAS Number: 3052146-54-7
Molecular Weight: 437.39
Research Area: Cancer
Target: Histone Methyltransferase;Isotope-Labeled Compounds